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Human erythrocytes of all four groups are agglutinated in high titer by 
Type  XIV  antipneumococcus  horse  serum.  Finland  and  Cumen  (1), 
who first noted this action, believe it to be the cause of certain untoward 
reactions which occur following the  therapeutic  administration  of  Type 
XIV serum.  No other type of antipneumococcus horse serum agglutinates 
erythrocytes in comparable titer; nor does any type of antipneumococcus 
rabbit serum, even that of Type XIV.  In an effort to explain the phe- 
nomenon the specific polysaccharide of the Type XIV Pneumococcus has 
been isolated and  its  chemical and immunological properties  have been 
investigated  (2).  There is a  striking resemblance between this bacterial 
carbohydrate and the specific  substance of blood group A  obtained from 
commercial  peptone.  Both  substances  are  nitrogenous  polysaccharides 
constituted from molecules of galactose and acetylglucosamine.  The two 
carbohydrates resemble each other in optical rotation, elementary analysis, 
and in their precipitation reactions with the salts of heavy metals.  The 
blood group A substance, however, appears to contain nitrogenous constit- 
uents  which  are  not present in the pneumococcus carbohydrate.  1  The 
present communication deals with the immunological properties of these 
two substances and their relation to the agglutination of human erythro- 
cytes by Type XrV antipneumococcus horse serum. 
A  detailed comparison of the Type XIV pneumococcus polysaccharide 
is possible only with the blood group A specific substance, since the chem- 
ical nature of the specific substances of the other blood groups has not as 
yet been sufficiently well characterized.  From the information available 
at present, however, one may assume that the specific  substances in the 
erythrocytes of B  and O groups are also carbohydrate in nature (3). 
t Personal communication  from Dr. Karl Landsteiner. 
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EXPEI~ ~ENTAL 
Materials 
Antisera.--Type  XIV  antipneumococcus  horse  serum  was  obtained  through  the 
courtesy of Dr.  Augustus Wadsworth and Dr.  Harold Lyail of the New  York State 
Department of Health.  The corresponding antipneumococcus rabbit serum was pro- 
duced in these laboratories, using the technique of Goodner, Horsfall, and Dubos (4). 
Erythrocytes.--Human erythrocytes of A, B, and O groups were obtained throughout 
the  experimental work  from  the  same  three  donors.  The  bloods were preserved in 
Rous-Turuer solution (5 cc. of 5.4 per cent dextrose and 2  cc. of 3.8 per cent sodium 
citrate for each 3 cc. of whole blood).  Erythrocytes were washed three times in normal 
saline before use. 
Specific Substances.--Type XIV pneumococcus specific polysaccharide was isolated 
from autolysates of whole bacteria grown in meat infusion broth containing peptone and 
dextrose.  The  group  A  specific  substance  was  isolated  from  commercial  peptone. 
(5).  Although probably not identical with the A hapten which occurs in erythrocytes, 
this substance inhibits the agglutination of human erythrocytes of group A by the serum 
of group B or O, and also inhibits the lysis of sheep erythrocytes by anti-A rabbit serum. 
It appears to be identical with the A substance obtained by Landsteiner and Chase (6) 
from commercial pepsin. 
Methods 
Absorption of Type XIV Antlpneumococcus Serum.--Absorption of the immune serum 
was accomplished by adding an equal volume of a  solution of the Type XIV polysac- 
charide or group A specific substance to a measured quantity of serum and allowing the 
mixture to stand overnight at 0 °.  The optimal concentration of each carbohydrate was 
predetermined by the method of Sabin (7).  The mixture was centrifuged at 0 ° and the 
supernatant liquid removed and used for subsequent tests. 
Absorption of antipneumococcus serum by erythrocytes required the use of large 
volumes of washed packed ceils.  After the ceils and serum were mixed and allowed to 
stand  several hours  at 0°C.,  the mixture was  centrifuged, and  the supernatant  fluid 
removed.  This procedure was repeated until no further agglutination of ceils by the 
serum could be detected. 
Agglutination of Erythrocytes.--One drop of a  2 per cent suspension of erythrocytes 
in saline was mixed with one drop of serum dilution and one drop of normal saline in a 
7  X  70 mm. agglutination tube.  The mixture was allowed to stand for 1 hour at room 
temperature.  The extent of agglutination was estimated by examining a  drop  of the 
mixture under low power magnification of the microscope.  The dilutions  recorded in 
the protocols refer to the initial dilution of serum used; the final titer was actually about 
three times that listed.  Test for inhibition of agglutination of erythrocytes was  per- 
formed similarly except that one drop of a saline solution of the inhibiting agent  (0.2 per 
cent A substance; 5 per cent glucosamine or galactose) was substituted for the drop of 
plain saline. 
Inhibition of Lysls  of Sheep Erythrocytes by Anti-A  Rabbit Serum.--This  test was 
performed according to the technique described by Landsteiner  (8).  The hemolytic 
serum was prepared by immunizing rabbits with human erythrocytes of group A.  Seven PAUL  B.  BEESON  AND  WALTHER  F,  GOEBEL  241 
rabbits were given three courses d  four daily intravenous injections, each containing 0.2 
cc. of packed erythrocytes.  Of the seven rabbits only two developed sheep cell lysins 
in high titer.  The serum used was obtained from these two rabbits. 
RESULTS 
Inhibition of Lysis of Sheep Erythrocytes.--Although group A  substance 
and Type XIV pneumococcus polysaccharide resemble one another chem- 
ically, they differ sharply in their ability to inhibit the lysis of sheep eryth- 
rocytes by anti-A rabbit serum in the presence of complement.  Group A 
substance is active when present in a concentration of 1:8,000,000 whereas 
the bacterial polysaccharide has no inhibiting action even in concentrations 
up to the limit of its solubility, which is about 1 per cent. 
Precipitation of Type XIV Pneumococcal Polysaccharide and  Group A 
Substance in Type XIV Antipneumococcus Sera.--Type  XIV pneumococcal 
polysaccharide precipitates in homologous antipneumococcus serum,  either 
horse or rabbit, in dilutions as great as one part in four million.  The reac- 
tion is  essentially independent of  temperature variation between 0  °  and 
37°C.  The group A substance also precipitates in Type X_IV horse serum, 
in dilutions as high as one part in  a  million.  The  latter reaction occurs 
only at or near 0°C.,  however; the precipitate thus  formed redissolves if 
the temperature is raised to  20°C.  or higher.  No  precipitation of the A 
substance occurs in  Type XIV  rabbit  serum, irrespective of the dilution 
or the temperature at which the reactions are carried out as can be seen 
from  Table  I.  The  difference in  the  precipitation  reactions  of  Type 
XIV  antipneumococcus horse  and  rabbit  sera parallels  the  difference in 
their action on human erythrocytes, which are agglutinated by Type XIV 
horse serum, but not by Type XIV rabbit serum (1). 
Absorption of Type XIV Antipneumococcus Horse Serum by Polysaccha- 
rides.--After  absorption  with  the  homologous  bacterial  polysaccharide 
Type XIV horse serum fails to precipitate with the group A  substance as 
seen from the results presented in Table II.  On the other hand, complete 
absorption of the same serum with A  substance seems to  cause no gross 
qualitative change in the precipitation with the Type XIV  specific poly- 
saccharide.  By  quantitative  methods,  however, it  has  been possible  to 
demonstrate  that  absorption  with  A  substance  removes  approximately 
50  per  cent  of  the  antibody  nitrogen  specifically precipitable  with  the 
Type XIV carbohydrate (2). 
The lack of complete reciprocal absorption of precipitin is in accordance 
with the observations of Finland and Curnen, who found that absorption 
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glutinins  while  absorption  with  human  erythrocytes  did  not  appreciably 
diminish  the  titer  of specific agglutinins  for  the  homologous  type  specific 
organisms. 
TABLE  I 
Precipitation of Group A Substance in Type XIV Antipneumococcus Horse and Rabbil Sera 
Type XIV 
antipneumococcus 
serunl 
Horse 
Rabbit 
Temperature 
*C. 
0 
37 
0 
37 
1-10,000 
+++ 
0 
Final dilution  of A substance 
1-50,000  1-250,0~0 
++  + 
0  0 
0  0 
0  0 
1-1,000,000 
.4_ 
0 
+ + + +  =  marked precipitation. 
+ + +  -- turbidity and granular precipitation. 
+ +  ffi turbidity and fine precipitation. 
+  =  turbidity. 
4-  =  faint cloud. 
0  =  no precipitation. 
TABLE  II 
Precipitation Reactions of Type XIV Antipneumococcus Horse Serum before and  after 
Absorption with Specific Substances 
Type XIV 
antipneumococcus 
horse serum 
Unabsorbed 
Absorbed  with  A 
substance 
Absorbed with XIV 
polysaccharide 
Precipitinogen 
XIV polysaccharide 
A substance 
XIV polysaccharide 
A substance 
XIV polysacchafide 
A substance 
1-10,000 
++++ 
+++ 
++++ 
0 
Final dilution of precipitinogen 
1~0,~  1~50,~ 
++++  +++ 
++  + 
+++±  ++± 
0  0 
0  0 
0  0 
1-1,000,000 
+± 
-4- 
+ 
0 
0 
0 
1-4,000,00~ 
-4- 
0 
-4- 
0 
Agglutination  of Erythrocytes  in  Type XlV  Antipneumococcus  Serum.- 
Table III illustrates the agglutinating action of Type XIV horse serum on 
human  erythrocytes  of A,  B,  and  O  groups.  A  noteworthy  point  is  the 
fact  that  there  is  no  significant  difference  in  the  titers  of  agglutinins  for 
the  cells of different blood groups.  In addition  it  can be seen that  when 
Type XIV horse serum is absorbed with the homologous bacterial polysac- 
charide  or  with  the  group  A  substance  there  is  a  marked  change  in  its PAUL  B: BEESON  AND  WALTHER  F. GOEBEL  243 
capacity to agglutinate human erythrocytes.  Absorption with the former 
completely removes the agglutinins  for erythrocytes.  Absorption with A 
substance,  although  not  removing the  agglutinins  completely,  diminishes 
the action of the serum markedly.  It should be noted, furthermore,  that 
absorption with A  substance reduces the agglutinins  not only for erythro- 
cytes of the same group but also for those of B and 0  groups as well.  The 
reduction is evident not only in the final liter,  but also in the strength  of 
TABLE  III 
Agglutination of Human Erythrocytes by Type XIV Antipneumococcus Horse Serum before 
and after Absorption with Specific Substances 
Type XlV antlpneumococcus 
horse serum 
Unabsorbed 
Absorbed  with  XIV  poly- 
saccharide 
Absorbed  with A substance 
Erythro- 
cytes of 
group 
A 
B 
0 
A 
B 
0 
A 
B 
0 
Serum dilution used 
1-10  1-20 
++++  +++4- 
++++  +++4- 
++++  +++4- 
o  o 
o  o 
[  o  o 
t  ++  +-4-  ++4-  ++ 
++  +4- 
1-40  1-80  __ 
~l  ++ 
++4-  ++ 
+++  +4- 
0  0 
0  0 
0  0 
+  + 
+  4- 
4-  .4- 
1-16(} 
+ 
+ 
+ 
+ + + +  = complete agglutination. 
+ + +  =  strong agglutination. 
+ +  = partial agglutination. 
+  =  detectable agglutination. 
4-  =  questionable agglutination. 
0  = no agglutination. 
agglutination  at  lower  dilutions  of  serum.  An  interesting  variation  of 
the above experiment is one in which A  substance  (0.2 per cent in saline) 
is added to the agglutinating  system at room temperature as seen in Table 
IV.  At this temperature  there is no visible precipitation  between A  sub- 
stance and Type XIV horse serum.  Nevertheless, there seems to be com- 
bination with at least a portion of the antibody, for the agglutination  titer 
is diminished  to  a  degree  comparable  with that  found in  the  A-absorbed 
serum.  Neither  glucosamine  nor  galactose,  the  hexoses from  which  the 
bacterial and blood group polysaccharides are constituted, have an inhibit- 
ing  action  on  the  agglutination  of  the  erythrocytes of  Type XIV  horse 
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Absorption  of Type  )(IV Antlpneumococcus  Horse Serum  with Erythro- 
cytes.--Absorption  of the hemagglutinins in  Type XIV horse serum with 
erythrocytes of each of the three groups requires reiatively large quantities 
of cells.  As was observed by Finland  and  Curnen,  absorption  with  the 
erythroeytes of one group removes the agglutinins not only for that group, 
TABLE  IV 
Inhibition of Agglutination of Human Erythrocytes in Type XIV Antipneumococcus Horse 
Serum by A Substance 
Inhibiting  agent 
None 
A substance 
Erythro- 
cytes of 
group 
A 
B 
0 
A 
B 
o 
Serum dilution  used 
1~10  1-20 
++++  +++4- 
++++  ++++ 
++++  +++4- 
++4-  +4- 
++4-  +4- 
+++  ++ 
1-40 
+++ 
++4- 
+++ 
+ 
+ 
+ 
1-80 
++ 
++ 
+4- 
+ 
+ 
4- 
I-I(~ 
+ 
+ 
+ 
TABLE  V 
Precipitin Reactions of Type XIV Antipneumococcus Horse Serum before and after 
Absorption with Human Erytkrocytes 
Type XIV 
antlpneumococcus 
rabbit  serum 
Unabsorbed 
Absorbed with eryth- 
rocytes of group 
A, B, or 0 
Precipltinogen 
Type XlVpolysac- 
chafide 
A substance 
Type XIV polysac- 
charide 
A substance 
I-I0,000 
++++ 
+++ 
++++ 
+4- 
Final dilution of precipitinogen 
1-50,000 
++++ 
++ 
+++4- 
4- 
1-250#00 
+++ 
+ 
++4- 
o 
1-1,000,000 
+4- 
4- 
+ 
0 
1-40000,00~ 
4- 
0 
4- 
0 
but also for the other two groups.  This fact seems to point to the presence 
of similarly reacting substances in the erythrocytes of the different groups. 
The precipitation reactions of Type XIV polysaccharide and A substance 
in the Type XIV horse serum absorbed with erythrocytes of the various 
blood groups are shown in Table V.  It will be observed that there is no 
appreciable  change  in  the  precipitin  reaction  with  Type  XIV  polysac- 
charide, whereas precipitation with A substance is markedly reduced.  Fur- 
thermore, the diminution of precipitins for A substance is the same regard- 
less of the group of erythrocytes used in the absorption. PAUL  B. BEESON  AND  WALTHER  ~.  GOEBEL  245 
DISCUSSION 
The development of lysins or aggiutinins for the erythrocytes of different 
animal species following immunization with bacterial cells has been noted 
on a number of occasions in the past.  For example, immunization of rab- 
bits with bacteria containing Forssman antigen causes the development of 
lysins  and  agglutinins  for  the  erythrocytes  of  sheep.  Buchbinder  (9) 
lists more than twenty bacterial species  which are known to contain Forss- 
man antigen, the Pneumococcus being one of  these.  Eisler (10) observed 
that immunization of rabbits  with paratyphoid B  organisms  resulted in 
the formation of agglutinins for human erythrocytes of group A.  He also 
reported that immunization of goats with Shiga bacilli caused the produc- 
tion of agglutinins for human erythrocytes of all four groups; although this 
phenomenon did not  occur when rabbits  or horses were so  immunized. 
Buchbinder (11)  found that immunization of the  rabbit,  guinea pig, rat, 
or monkey with bacteria belonging to the hemorrhagic septicemia group 
evoked the production of lysins and agglutinlns for the  erythrocytes of 
many varieties of birds. 
It would seem that the special case with which this communication is 
concerned, that is, the agglutination of human erythrocytes by the sera of 
horses  immunized  with  Type  XIV  pneumococci,  may  be  regarded  as 
another example of a heterogenetic relationship.  The fact that this rela- 
tionship is between horse serum, the serum of an animal which contains the 
Forssman antigen, and erythrocytes of all four human blood groups would 
make it improbable that it belongs to the Forssman classification.  It is 
well known that human erythrocytes of groups B  and O do not contain 
Forssman  antigen. 
The presence in Type XIV antipneumococcus horse serum of antibodies 
reactive with human erythrocytes in contrast to their absence in the cor- 
responding antiserum of the rabbit, is evidence of differences in the immune 
response of different animal species.  Well and Sherman (12) call attention 
to the fact that rabbit  erythrocytes are also agglutinated by Type XIV 
antipneumococcus horse serum.  They infer from this that in the erythro- 
cytes of the rabbit  there is present  an antigen which resembles that in 
human erythrocytes and this species is therefore incapable of evoking ag- 
glutinins for human cells.  There can be little doubt that the erythrocyte- 
agglutinating antibodies in Type XIV horse serum are the specific  anti- 
carbohydrate  immune  bodies  evoked  by  the  encapsulated  Type  XIV 
pneumococcus for they can be removed entirely by absorption with the 
Type XIV specific polysaccharide.  It appears therefore that the phenom- 246  CAPSULAR  POLYSACCIIARIDE  OF  TYPE  XIV  PNEUMOCOCCUS 
enon of erythrocyte agglutination is a cross-reaction between the type spe- 
cific anticarbohydrate immune bodies of the horse serum and the human 
blood  cells.  Cross-reactions  between  pneumococcal  types  are  notably 
more common with horse antisera than with rabbit antisera.  White (13) 
states that at the Massachusetts Antitoxin and Vaccine Laboratory it was 
observed that even when animals were immunized with the same vaccines 
horse antisera often gave cross-reactions, while rabbit antisera tended to 
be type specific.  In this laboratory we have shown that certain artificial 
antigens containing hexuronic acids and even benzene sulfonic and carbox- 
ylic  acids precipitate  with  antipneumococcal horse sera of various types 
(14).  Such  antigens,  however,  show  no  precipitation  reaction  in  the 
corresponding immune rabbit sera.  Heidelberger and Kendall (15)  found 
that  Type  III  antipneumococcus horse  sera  precipitated  certain  of  the 
hydrolytic products of the Type III pneumococcus  polysaccharide, whereas 
Type III  antipneumococcus rabbit  serum did not.  These investigators 
(16)  also  showed by  quantitative  methods that  antipneumococcal horse 
sera Types III and VIII gave extensive cross-precipitation reactions with 
the heterologous bacterial  carbohydrates,  while  rabbit  antisera  of  these 
same types reacted almost exclusively with the homologous  polysaccharides. 
In the present instance it is shown that the A substance precipitates with 
the anticarbohydrate immune bodies of Type XIV horse serum, but not 
at all with those of the corresponding rabbit antiserum. 
The serological relationship between the Type XIV and group A specific 
substances appears to be correlated with similarities in the chemical con- 
stitution of these specific polysaccharides.  Differences in their serological 
behavior as  demonstrated by  the lack of reciprocal absorption,  strongly 
support the  chemical evidence of similarity rather  than identity of  the 
specific  substances.  It  should  be  emphasized here  that  the  "group  A 
substance" used in these experiments is probably not identical with the 
blood group A hapten as it occurs naturally in the intact human erythro- 
cyte.  The structure of the specific substances of the other blood groups is 
as yet insufficiently established to permit comparison with the group A and 
the  Type  XIV  pneumococcal polysaccharides.  It  may  be  that  some 
common grouping in the blood group substances and the Type XIV poly- 
saccharide is responsible for the interaction of Type XIV antipneumococ- 
cus horse serum and human erythrocytes of all groups. 
1.  The agglutination of human erythrocytes and the precipitation of the 
blood group A  substance by  Type XIV  antipneumococcus horse  serum PAUL B.  BEESON AND  WALTHER 1  ~.  GOEBEL  247 
are  properties  of  the  specific  anticarbohydrate  immune  bodies  in  the 
serum. 
2.  Absorption  of  Type  XIV  antipneumococcus horse  serum  with  the 
homologous bacterial polysaccharide removes the  agglutinins for human 
erythrocytes as well as the precipitins for the group A substance. 
3.  Absorption  of  Type  XIV  antipneumococcus horse  serum  with  the 
group A substance markedly diminishes the ability of the serum to agglu- 
tinate  erythrocytes of  all  groups. 
4. Absorption of Type XIV antipneumococcus horse serum with human 
erythrocytes causes a marked diminution in the precipitation with group A 
substance. 
5.  The  chemical and  immunological relationship  between  the  specific 
substances  of  blood group  A  and  the  Type XIV  Pneumococcus is  dis- 
cussed. 
BIBLIOGRAPHY 
i. Finland,  M., and Curnen, E. C.,  Sd~ce, 1938,  87, 417. 
2. Goebel,  W. F., Beeson,  P. B., and Hoagland, C. L.,  J. Biol.  Chem., 1939,  129,  455. 
3.  Hallauer, C., Z. Immunit~2sforsch., 1934, 83, 114. 
4.  Goodner, K., Horsfall, F. L., Jr., and Dubos, R. J., J, Immunol., 1937, 68, 279. 
5.  Goebel, W. F., Y. Exp. Med., 1938, 68, 221. 
6. Landsteiner, K., and Chase, M. W., Y. Exp. Med., 1936, 68, 813. 
7. Sabin, A. B., Y. Exp. Med., 1931, 58, 93. 
8. Landsteiner, K., J. Exp. Med., 1936, 68, 185. 
9.  Buchbinder, L., Arch. Path., 1935, 19, 841. 
10. Eisler, M., Z. Immunit~tsforsch., 1931, 78, 37. 
11. Buchbinder, L., Y. Imraunol., 1934, 26, 215. 
12. Well, A. J., and Sherman,  E., J. Immunol., 1939, 86, 139. 
13. White, B., Biology of pneumococcus,  New York, Commonwealth Fund, 1938, 594. 
14.  Goebel, W. F., and Hotchkiss, R. D., 9". Exp. Med., 1937, 66, 191. 
15. Heidelberger, M., and Kendall, F. E., Y. Exp. Med.,  1933, 57, 373. 
16. Heidelberger, M., Kabat, E. A., and Shrivastava, D. L., Y. Exp. Med., 1937, 65,487. 